# Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

> **NCT01850849** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 23 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** LEO 39652 cream
- **DRUG:** cream vehicle

## Key facts

- **NCT ID:** NCT01850849
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850849, "Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01850849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*